Your browser doesn't support javascript.
loading
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week.
Januzzi, James L; Canty, John M; Das, Saumya; DeFilippi, Christopher R; Gintant, Gary A; Gutstein, David E; Jaffe, Allan; Kaushik, Emily P; Leptak, Christopher; Mehta, Cyrus; Pina, Ileana; Povsic, Thomas J; Rambaran, Curtis; Rhyne, Rhonda F; Salas, Maribel; Shi, Victor C; Udell, Jacob A; Unger, Ellis F; Zabka, Tanja S; Seltzer, Jonathan H.
Afiliação
  • Januzzi JL; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Baim Institute for Clinical Research, Boston, Massachusetts, USA. Electronic address: jjanuzzi@partners.org.
  • Canty JM; Division of Cardiovascular Medicine, University at Buffalo and Department of Veterans Affairs, Western New York Health Care System, Buffalo, New York, USA.
  • Das S; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • DeFilippi CR; Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
  • Gintant GA; Department of Integrative Pharmacology, Integrated Sciences and Technology, AbbVie Pharmaceuticals, Cambridge, Massachusetts, USA.
  • Gutstein DE; Cardiovascular Metabolism Discovery, Janssen Pharmaceuticals, Titusville, New Jersey, USA.
  • Jaffe A; Department of Cardiovascular Diseases and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kaushik EP; Global Drug Safety Research and Evaluation, Takeda Pharmaceuticals, Boston, Massachusetts, USA.
  • Leptak C; Biomarker Qualification Program, Office New Drugs, Center for Drug Development and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA.
  • Mehta C; Harvard TH Chan School of Public Health and Cytel Inc., Boston, Massachusetts, USA.
  • Pina I; Wayne State University, Detroit, Michigan, USA.
  • Povsic TJ; Duke Clinical Research Institute and Department of Medicine, Duke University, Durham, North Carolina, USA.
  • Rambaran C; Daiichi-Sankyo, Inc., Basking Ridge, New Jersey, USA.
  • Rhyne RF; Prevencio, Inc., Kirkland, Washington, USA.
  • Salas M; Daiichi-Sankyo, Inc., Basking Ridge, New Jersey, USA; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Shi VC; Novartis Pharmaceuticals Corporation, Basel, Switzerland.
  • Udell JA; Cardiovascular Division, Women's College Hospital and Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Unger EF; Office of Cardiology, Hematology, Endocrinology, and Nephrology, Office of New Drugs, Center for Drug Development and Research, United States Food and Drug Administration, Silver Spring, Maryland, USA.
  • Zabka TS; Development Sciences-Safety Assessment, Genentech Inc., San Francisco, California, USA.
  • Seltzer JH; WCG Clinical and WCG-ACI Clinical, Bala Cynwood, Pennsylvania, USA.
J Am Coll Cardiol ; 77(15): 1922-1933, 2021 04 20.
Article em En | MEDLINE | ID: mdl-33858628
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Doenças Cardiovasculares / Ensaios Clínicos como Assunto Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Doenças Cardiovasculares / Ensaios Clínicos como Assunto Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2021 Tipo de documento: Article